AR062711A1 - Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad - Google Patents

Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad

Info

Publication number
AR062711A1
AR062711A1 ARP070103969A ARP070103969A AR062711A1 AR 062711 A1 AR062711 A1 AR 062711A1 AR P070103969 A ARP070103969 A AR P070103969A AR P070103969 A ARP070103969 A AR P070103969A AR 062711 A1 AR062711 A1 AR 062711A1
Authority
AR
Argentina
Prior art keywords
proteins
purification
affinity chromatography
arginine
product
Prior art date
Application number
ARP070103969A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39158086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR062711(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR062711A1 publication Critical patent/AR062711A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

La presente se refiere a métodos para aislar un producto y/o reducir la turbidez y/o impurezas de un fluido de carga que comprende el producto y una o más impurezas al pasar el fluido de carga a través de un medio, seguido por al menos una solucion de lavado que comprende arginina o un derivado de arginina, y recolectar el producto al usar una solucion de elucion. La presente se refiere además a un producto preparado al usar un método corno se describe en la presente.
ARP070103969A 2006-09-08 2007-09-07 Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad AR062711A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84308406P 2006-09-08 2006-09-08

Publications (1)

Publication Number Publication Date
AR062711A1 true AR062711A1 (es) 2008-11-26

Family

ID=39158086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103969A AR062711A1 (es) 2006-09-08 2007-09-07 Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad

Country Status (17)

Country Link
US (2) US8350013B2 (es)
EP (1) EP2059258B1 (es)
JP (1) JP5386354B2 (es)
KR (1) KR20090064377A (es)
CN (1) CN101511387A (es)
AR (1) AR062711A1 (es)
AU (1) AU2007292253A1 (es)
BR (1) BRPI0716597A2 (es)
CA (1) CA2661645C (es)
CL (1) CL2007002615A1 (es)
ES (1) ES2764222T3 (es)
IL (1) IL197053A0 (es)
MX (1) MX2009002576A (es)
PE (1) PE20080913A1 (es)
RU (1) RU2009106083A (es)
TW (1) TW200821026A (es)
WO (1) WO2008031020A2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9375499B2 (en) * 2006-07-14 2016-06-28 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
SG174804A1 (es) 2006-09-13 2011-10-28 Abbott Lab
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
US8853371B2 (en) * 2006-10-19 2014-10-07 Janssen Biotech, Inc. Process for preparing unaggregated antibody Fc domains
US8669045B2 (en) * 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
AU2009347206C1 (en) * 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
DK2350271T3 (en) 2008-11-20 2016-04-04 Biogen Ma Inc ARGININ INACTIVATION OF ENVIRONMENT VIRA
JP2010209068A (ja) 2009-03-11 2010-09-24 Wyeth Llc 小モジュラー免疫薬タンパク質を精製する方法
EP3715356B1 (en) 2009-12-18 2023-10-11 CSL Limited Method of purifying polypeptides
LT2513134T (lt) * 2009-12-18 2017-11-27 Novartis Ag Praplovimo tirpalas ir afininės chromatografijos metodas
SG182553A1 (en) 2010-01-22 2012-08-30 Boehringer Ingelheim Int Chromatographic method for purifying fc-containing proteins
ES2671347T3 (es) * 2010-06-21 2018-06-06 Kyowa Hakko Kirin Co., Ltd. Procedimiento para purificar una proteína que utiliza un aminoácido
BR112013030628B1 (pt) * 2011-06-01 2022-01-25 Novartis Ag Método para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade, e método para produção de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando uma coluna de proteína a
HRP20240230T1 (hr) 2011-10-11 2024-04-26 F. Hoffmann - La Roche Ag Poboljšani sklop bispecifičnih protutijela
US20130109807A1 (en) * 2011-10-26 2013-05-02 Bio-Rad Laboratories, Inc. Removal of virucidal agents in mixed mode chromatography
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
KR101414897B1 (ko) 2013-11-29 2014-07-04 씨제이헬스케어 주식회사 다베포에틴 알파의 정제 방법
WO2016046118A1 (de) 2014-09-24 2016-03-31 Basf Se Verfahren zur herstellung von terephthalsäurediestern mit rückalkohol-entwässerung
CN107074720B (zh) 2014-09-24 2021-01-08 巴斯夫欧洲公司 以反应混合物的循环制备对苯二甲酸二酯的方法
BR112017005850A2 (pt) 2014-09-24 2018-02-06 Basf Se processo e aparelho para preparação de um diéster tereftálico.
PL3197861T3 (pl) 2014-09-24 2019-01-31 Basf Se Sposób wytwarzania diestrów kwasu tereftalowego
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
MX2017011121A (es) 2015-03-13 2017-11-28 Bristol Myers Squibb Co Uso de lavados alcalinos durante la cromatografia para remover impurezas.
HRP20160086A2 (hr) 2016-01-27 2017-08-11 Sveučilište u Zagrebu Eluens za imunoafinitetnu kromatografiju virusa i proteina
DE102016106271B4 (de) 2016-04-06 2018-03-29 Axagarius Gmbh & Co. Kg Aufreinigung von Nukleinsäure aus einer Nukleinsäure und Endotoxin enthaltenden Probe
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
CN109071613A (zh) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 分离基质
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
EP3487868B1 (en) * 2016-07-25 2024-08-28 Cephalon, Inc. Affinity chromatography wash buffer
DK3510042T3 (da) * 2016-09-07 2024-06-10 Glaxosmithkline Ip Dev Ltd Fremgangsmåde til rensning af antistoffer
IL299270B2 (en) * 2017-01-30 2024-10-01 Regeneron Pharmaceuticals Inc Preparations and methods for reducing biological load in chromatography
TW202000891A (zh) * 2018-03-07 2020-01-01 英商葛蘭素史克智慧財產發展有限公司 純化抗體之方法
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
CN108586606A (zh) * 2018-04-24 2018-09-28 上海药明生物技术有限公司 一种用于去除抗体蛋白中内毒素的方法
JP2023523324A (ja) * 2020-04-27 2023-06-02 アレクシオン ファーマシューティカルズ, インコーポレイテッド 抗体のプロテインaクロマトグラフィー精製
AU2021265346A1 (en) * 2020-05-01 2022-12-22 Kashiv Biosciences, Llc An improved process of affinity chromatography
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法
WO2024126337A1 (en) * 2022-12-12 2024-06-20 H. Lundbeck A/S Arginine wash in protein purification

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
US4230697A (en) 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
US4624932A (en) 1978-09-13 1986-11-25 Samuel Bogoch Recognins and their chemoreciprocals
EP0009781B2 (en) 1978-09-29 1986-04-23 Mitsubishi Kasei Corporation Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
JPS5569595A (en) 1978-11-20 1980-05-26 Suguru Abe Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
CA1172980A (en) 1979-04-02 1984-08-21 Kenji Takemoto Pentadecapeptide and process for the preparation thereof
DE3034529C2 (de) 1980-09-12 1982-09-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel
DE3110561A1 (de) 1981-03-18 1982-11-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Chemorekrutine der leukozyten und des entszuendungsgewebes: eine neue klasse natuerlicher leukopoetine zurselektiven chemorekrutierung von leukozyten aus dem knochenmark in den blutstrom (leukozytose- und linskverschiebungsreaktion)
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4532207A (en) 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4390468A (en) * 1982-08-04 1983-06-28 Maruzen Oil Co., Ltd. Preparation of antitumor agent from shellfish
US4882421A (en) 1982-09-23 1989-11-21 Alfacell Corporation Pharmaceutical for treating tumors and method for making it
US4568545A (en) 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
JPS5980613A (ja) 1982-10-29 1984-05-10 Mitsui Toatsu Chem Inc 新規なプラスミノ−ゲン・アクチベ−タ及びその製造方法
US4880914A (en) 1982-11-09 1989-11-14 Cornell Research Foundation, Inc. Assay for qualitatively and/or quantitatively measuring hLH or hCG in body fluids and reagents therefor
US4966888A (en) 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
GB8314362D0 (en) 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
US4456676A (en) 1983-06-10 1984-06-26 E. I. Du Pont De Nemours And Company Amine stabilizers for wash-off systems
US4444760A (en) 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
JPS60184098A (ja) * 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
JPH0794473B2 (ja) 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
US4670539A (en) 1984-07-27 1987-06-02 Board Of Regents, The University Of Texas Peptide growth factors derived from estrogen responsive kidney tissue
US5132214A (en) 1986-04-09 1992-07-21 Monsanto Company Large scale production of plasminogen activator from normal human colon cells
US5030559A (en) 1986-04-01 1991-07-09 Board Of Regents, The University Of Texas System Methods and compositions for the identification of metastatic human tumors
US5213970A (en) 1987-01-23 1993-05-25 Board Of Regents, The University Of Texas System Method for obtaining soluble antitumor factor
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
JPH01238534A (ja) 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5760183A (en) 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
DE3914354C1 (es) 1989-04-29 1990-10-31 Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
FR2676231A1 (fr) 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
JPH0518950A (ja) 1991-07-09 1993-01-26 Showa Denko Kk アフイニテイクロマトグラフイー用吸着担体
DK0547544T3 (da) 1991-12-18 1997-09-08 Hoechst Ag Fremgangsmåde til fremstilling af insulinholdige opløsninger.
US5372942A (en) 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
CH685498A5 (fr) 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
JP2767521B2 (ja) 1992-09-04 1998-06-18 農林水産省食品総合研究所長 新規抗腫瘍性蛋白質とその製造法および該蛋白質を有効成分として含有する抗腫瘍剤
JP3801196B2 (ja) 1993-03-09 2006-07-26 ジェンザイム・コーポレイション 乳からの対象化合物の単離
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6607884B1 (en) * 1993-03-19 2003-08-19 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-8
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5330972A (en) 1993-05-28 1994-07-19 Abbott Laboratories Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
JP2971293B2 (ja) 1993-06-11 1999-11-02 株式会社細菌化学研究所 溶血性連鎖球菌の産生する生理活性物質及びその製造法
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5478924A (en) * 1994-02-16 1995-12-26 Cramer; Steven M. Displacement chromatography of proteins using low molecular weight displacers
US5570389A (en) 1994-06-30 1996-10-29 Compaq Computer Corporation Method for reliable exchange of modem handshaking information over a cellular radio carrier
US5659017A (en) 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
SE9603068D0 (sv) 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
DE69739673D1 (de) * 1996-11-27 2009-12-31 Genentech Inc Affinitätsreinigung von Polypeptid-Proteinen auf einer Protein A Matrix
ZA9711580B (en) * 1996-12-25 1999-09-23 Hoechst Marion Roussel Ltd Process for the production of purified dimeric bone morphogenetic factors.
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
US6451260B1 (en) 1997-08-26 2002-09-17 Dyax Corp. Method for producing microporous elements, the microporous elements thus produced and uses thereof
US20030036629A1 (en) * 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
US6673629B2 (en) 1998-01-15 2004-01-06 Abbott Laboratories Neutralization of polycations in a chromatographic device for whole blood use
DE19937219A1 (de) 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie
US6770457B1 (en) 1998-05-28 2004-08-03 Korea Green Cross Corporation Process of purifying angiogenesis inhibitors
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
GB9815666D0 (en) 1998-07-17 1998-09-16 Smithkline Beecham Plc Novel compounds
RU2144082C1 (ru) 1998-07-23 2000-01-10 Навашин Петр Сергеевич Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека
RU2143492C1 (ru) 1998-07-23 1999-12-27 Навашин Петр Сергеевич Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
US7300753B2 (en) 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US7198896B2 (en) * 1998-09-04 2007-04-03 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US6939545B2 (en) * 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
US7307161B1 (en) 1999-04-28 2007-12-11 Genetics Institute, Llc Human Gil-19/AE289 polynucleotides
DE19937218A1 (de) 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
US6774102B1 (en) 1999-09-29 2004-08-10 Gambro Dialysatoren Gmbh & Co. Kg Extracorporeal endotoxin removal method
AU781023B2 (en) 1999-11-04 2005-04-28 Genentech Inc. Reversed-phase HPLC assay for plasminogen activators
US6825164B1 (en) * 2000-08-14 2004-11-30 The Trustees Of Columbia University In The City Of New York Method to increase cerebral blood flow in amyloid angiopathy
DE10046960A1 (de) 2000-09-22 2002-04-11 Roche Diagnostics Gmbh Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) * 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7638604B2 (en) 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
US20040058445A1 (en) * 2001-04-26 2004-03-25 Ledbetter Jeffrey Alan Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
WO2002098531A1 (en) * 2001-06-05 2002-12-12 Genetics Institute, Llc Methods for purifying highly anionic proteins
US20040203115A1 (en) 2001-10-09 2004-10-14 Giardina Steven L Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
US20040161776A1 (en) 2001-10-23 2004-08-19 Maddon Paul J. PSMA formulations and uses thereof
US7118675B2 (en) * 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
CA2473144C (en) * 2002-02-05 2013-05-28 Genentech, Inc. Protein purification
AU2003279240A1 (en) 2002-06-21 2004-01-06 Genetix Pharmaceuticals, Inc. Methods for purifying viral particles for gene therapy
US7261893B2 (en) * 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
RU2409591C2 (ru) * 2003-10-27 2011-01-20 Вайет Удаление агрегатов с высокой молекулярной массой путем хроматографии на гидроксиапатитах
US7065110B2 (en) * 2004-01-20 2006-06-20 Northrop Grumman Corporation Scalable wavelength shifted laser source and method
US8084032B2 (en) * 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
US7501121B2 (en) * 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
CN104610422A (zh) * 2005-03-11 2015-05-13 惠氏公司 弱分配层析的方法

Also Published As

Publication number Publication date
EP2059258A4 (en) 2012-05-02
WO2008031020A3 (en) 2008-10-23
RU2009106083A (ru) 2010-10-20
CA2661645A1 (en) 2008-03-13
JP2010502737A (ja) 2010-01-28
EP2059258B1 (en) 2019-11-13
US20080064860A1 (en) 2008-03-13
ES2764222T3 (es) 2020-06-02
US7714111B2 (en) 2010-05-11
US20080064861A1 (en) 2008-03-13
JP5386354B2 (ja) 2014-01-15
BRPI0716597A2 (pt) 2013-10-08
US8350013B2 (en) 2013-01-08
WO2008031020A2 (en) 2008-03-13
PE20080913A1 (es) 2008-08-21
CL2007002615A1 (es) 2008-04-18
EP2059258A2 (en) 2009-05-20
MX2009002576A (es) 2009-03-20
TW200821026A (en) 2008-05-16
IL197053A0 (en) 2009-11-18
CA2661645C (en) 2016-11-08
KR20090064377A (ko) 2009-06-18
CN101511387A (zh) 2009-08-19
AU2007292253A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
AR062711A1 (es) Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
AR069097A1 (es) Purificacion de anticuerpos por cromatografia de intercambio cationico
UY31789A1 (es) Composiciones de insulina de super rápida actuación
WO2007109163A3 (en) Wash buffer and method of using
MX2012007103A (es) Solucion y metodo de lavado por cromatografia de afinidad.
AR086525A1 (es) Metodo de purificacion de anticuerpos
AR063587A1 (es) Preparcion liquida que comprende pimobendan
MEP44608A (en) Methods for treating infectious disease exacerbated asthma
SG149759A1 (en) Media for affinity chromatography
WO2009118375A3 (en) Stabilized liquid enzyme compositions
SG10201908027QA (en) Use of alkaline washes during chromatography to remove impurities
SG194460A1 (en) Wash solution and method for affinity chromatography
WO2009123764A3 (en) Compositions and use of epas1 inhibitors
NZ590257A (en) Method of preparing alpha-1 proteinase inhibitor
TR201911082T4 (tr) K vitaminine bağımlı proteinlerin saflaştırılması için bir işlem.
ES2674177T3 (es) Preparación de suero
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
WO2010014922A3 (en) Protein purification tags and uses thereof
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.
MY157846A (en) Process for the purification of fc-containing proteins
UY33459A (es) Purificación de productos anfóteros, o de productos propensos a ser convertidos en productos anfóteros
EA200970074A1 (ru) Химический способ создания давления
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.
MX2014003415A (es) Mediadores azo.

Legal Events

Date Code Title Description
FB Suspension of granting procedure